Zhang, Ying http://orcid.org/0000-0003-3697-6702
Yu, Bing http://orcid.org/0000-0003-4818-1077
Qi, Qibin http://orcid.org/0000-0002-2687-1758
Azarbarzin, Ali
Chen, Han
Shah, Neomi A.
Ramos, Alberto R.
Zee, Phyllis C.
Cai, Jianwen
Daviglus, Martha L.
Boerwinkle, Eric
Kaplan, Robert
Liu, Peter Y. http://orcid.org/0000-0003-2439-0915
Redline, Susan http://orcid.org/0000-0002-6585-1610
Sofer, Tamar http://orcid.org/0000-0001-8520-8860
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL161012)
Added, but somehow it doesn't save. Hopefully this text comment will help.
Article History
Received: 14 July 2023
Accepted: 12 February 2024
First Online: 28 February 2024
Competing interests
: S.R. has received consulting fees from Eli Lilly Inc and is an advisor to ApniMed Inc. This work is not related to this paper. A.A. reports grant support from Somnifix and serves as a consultant for Somnifix, Respicardia, Eli Lilly and Apnimed. Apnimed is developing pharmacological treatments for Obstructive Sleep Apnea. A.A. reports patent application related to the measurement of hypoxic burden of sleep apnea. A.A.’s interests were reviewed by Brigham and Women’s Hospital and Mass General Brigham in accordance with their institutional policies. A.R.R. is a member of sleep disorders research advisory board for the NIH/NHLBI. P.C.Z. is past president of the World Sleep Society, consultant for Eisai, Idorsia, CVS Caremark and Jazz. This work is not related to this paper. Y.Z., B.Y., Q.Q., H.C., N.A.S., J.C., M.L.D., E.B., R.K., P.Y.L. and T.S. have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the interpretation of the article.